Genelux Corporation Common Stock
GNLX
$2.32-7.94%
End of day · as of Oct 15, 2026, 2:00 AM ET
Mkt cap
$130.56M
EV/Sales
15653.8
P/E ratio
N/A
FY2025 Revenue
$8,000
EPS (FY2025)
$-0.86
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-401812.50%
Beta
-0.52
Div yield
N/A
Sector
Healthcare
Genelux Corporation Common Stock (GNLX) is a biotechnology company listed on US.
Latest reported GNLX revenue for 2025-12-31 was $8.0K. Net income was -$32.1M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. GNLX currently screens at market cap $130.6M.
Use this GNLX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full GNLX income, balance, and cash tables.
Genelux Corporation Common Stock (GNLX) is a biotechnology company in the Healthcare sector.
Latest cached Genelux Corporation Common Stock (GNLX) revenue for Dec 31, 2025 was $8.0K. Net income was -$32.1M. Statements: https://lician.com/financials/gnlx
Genelux Corporation Common Stock (GNLX) market capitalization is $130.6M on the latest cached snapshot.
Genelux Corporation Common Stock (GNLX) cached previous close $2.52; day range $2.32 – $2.48; volume 409,781. Session quote: https://lician.com/quote/gnlx
Genelux Corporation Common Stock (GNLX) latest cached earnings event is "GNLX earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached GNLX filing is 8-K · Jun 22, 2026. Filings: https://lician.com/sec/gnlx